Olanzapine Tablets, USP 2.5 mg, 30-count bottle, Rx Only, Manufactured for: Macleods Pharma USA, ...

FDA Recall #D-0154-2025 — Class II — November 25, 2024

Recall #D-0154-2025 Date: November 25, 2024 Classification: Class II Status: Ongoing

Product Description

Olanzapine Tablets, USP 2.5 mg, 30-count bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540, Manufactured for: Macleods Pharma USA Inc. Princeton, NJ,08540: Manufactured by: Macleods Pharmaceuticals, Ltd. Baddi Himachal Pradesh, INDIA, NDC 33342-067-07.

Reason for Recall

Failed Impurities/Degradation Specifications

Recalling Firm

Macleods Pharmaceuticals Ltd — Mumbai

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

15,744 30-count bottles

Distribution

Nationwide in the USA

Code Information

Lot# BOB12318A Exp 07/31/2027

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated